Crinetics Pharmaceuticals, Inc. (CRNX)
Develops oral medicines to treat rare hormone-related diseases and tumors.
$83.89+0.00%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+201.3%
The outlook
CRNX is trading near its 52-week high and above both its 50- and 200-day moving averages, signaling a strong uptrend. Analyst sentiment is mixed with a Hold consensus, and the average price target sits about 2% above the current level. The overall data shows positive momentum, though analyst coverage leans cautious.
What’s behind the score
Analyst consensusHold — 2.7 avg of 10 analysts
Price trendAbove its 50- & 200-day averages
52-week range100% of the way from its 52-week low to high
Price targetAvg target +2% vs current price
Analyst price target
~12-month · 10 analysts$85.50average target+1.9% vs now
Now $83.89
Low $85.00High $90.00
Published targets from Wall Street analysts (public data) — what analysts expect over roughly a year. This is not a StockGlow forecast and not a recommendation. Analyst targets are frequently wrong.
Market cap
$8.88B
52-wk high
$84.00
52-wk low
$25.83
50-day avg
$50.25
200-day avg
$45.25
Trailing P/E
—